In terms of the impact, I think probably the biggest impact we can demonstrate occurred after the program was initiated in 2003. At that time there were, I believe, four pediatric vaccines that had been approved and were on the market. What happens is that the federal government approves them; then they go through a review process through the National Advisory Committee on Immunization, and then it's up to the provinces to adopt them into their immunization schedules.
What we saw with that money in 2003 was that the provinces put them into their schedules at a much quicker rate than they had previously. We think that demonstrated benefits. We are now starting to see the health benefits. We are also starting to see the health benefits of the HPV vaccination program, which was announced in 2007, with a reduction in various symptoms such as genital warts.
We think those are the kinds of things that come of that investment.